Sarepta Therapeutics Inc Annual Shareholders Meeting Transcript
Good day, ladies and gentlemen, and welcome to the Sarepta Therapeutics 2020 Virtual Annual Meeting of Stockholders. As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, Dr. Kathy Behrens, Chairwoman of Sarepta Therapeutics. Please go ahead.
Good morning. Welcome to the 2020 Annual Meeting of Stockholders for Sarepta Therapeutics. It's now 9:00 a.m., and the meeting will please come to order. My name is Dr. M. Kathleen Behrens, and as Chairwoman of the Board of Directors of Sarepta, I will be presiding over this meeting. Doug Ingram, President and Chief Executive Officer of Sarepta, will also preside over portions of the meeting. Ty Howton, Executive Vice President, General Counsel and Corporate Secretary, will record the proceedings.
As all of you are aware, we are living in an extraordinary time. COVID-19 risk mitigation measures are keeping most of us in our homes and away from our typical daily routines. I hope that all
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |